Growth Metrics

Burning Rock Biotech (BNR) Net Income towards Common Stockholders: 2019-2024

Historic Net Income towards Common Stockholders for Burning Rock Biotech (BNR) over the last 6 years, with Dec 2024 value amounting to -$45.9 million.

  • Burning Rock Biotech's Net Income towards Common Stockholders fell 91.19% to $16.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$24.9 million, marking a year-over-year decrease of 106.92%. This contributed to the annual value of -$45.9 million for FY2024, which is 49.80% up from last year.
  • According to the latest figures from FY2024, Burning Rock Biotech's Net Income towards Common Stockholders is -$45.9 million, which was up 49.80% from -$91.4 million recorded in FY2023.
  • Burning Rock Biotech's 5-year Net Income towards Common Stockholders high stood at -$45.9 million for FY2024, and its period low was -$140.2 million during FY2022.
  • Its 3-year average for Net Income towards Common Stockholders is -$92.5 million, with a median of -$91.4 million in 2023.
  • Per our database at Business Quant, Burning Rock Biotech's Net Income towards Common Stockholders slumped by 154.76% in 2020 and then skyrocketed by 49.80% in 2024.
  • Yearly analysis of 5 years shows Burning Rock Biotech's Net Income towards Common Stockholders stood at -$62.4 million in 2020, then slumped by 99.86% to -$124.7 million in 2021, then decreased by 12.43% to -$140.2 million in 2022, then surged by 34.83% to -$91.4 million in 2023, then spiked by 49.80% to -$45.9 million in 2024.